Compare GSK Pharma with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA CIPLA GSK PHARMA/
CIPLA
 
P/E (TTM) x 77.4 31.1 248.5% View Chart
P/BV x 19.0 4.8 399.5% View Chart
Dividend Yield % 1.8 0.4 413.3%  

Financials

 GSK PHARMA   CIPLA
EQUITY SHARE DATA
    GSK PHARMA
Mar-21
CIPLA
Mar-20
GSK PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,805586 308.3%   
Low Rs1,155357 323.6%   
Sales per share (Unadj.) Rs188.8212.5 88.9%  
Earnings per share (Unadj.) Rs21.119.2 110.2%  
Cash flow per share (Unadj.) Rs25.832.8 78.6%  
Dividends per share (Unadj.) Rs30.004.00 750.0%  
Dividend yield (eoy) %2.00.8 238.8%  
Book value per share (Unadj.) Rs88.5194.9 45.4%  
Shares outstanding (eoy) m169.41806.24 21.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x7.82.2 353.5%   
Avg P/E ratio x70.024.6 285.1%  
P/CF ratio (eoy) x57.314.4 399.4%  
Price / Book Value ratio x16.72.4 691.6%  
Dividend payout %141.920.8 680.7%   
Avg Mkt Cap Rs m250,695379,858 66.0%   
No. of employees `000NANA-   
Total wages/salary Rs m6,14730,270 20.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m31,989171,320 18.7%  
Other income Rs m1,1063,694 29.9%   
Total revenues Rs m33,094175,014 18.9%   
Gross profit Rs m5,22731,061 16.8%  
Depreciation Rs m79311,000 7.2%   
Interest Rs m351,974 1.8%   
Profit before tax Rs m5,50521,782 25.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,9246,312 30.5%   
Profit after tax Rs m3,58115,470 23.2%  
Gross profit margin %16.318.1 90.1%  
Effective tax rate %34.929.0 120.6%   
Net profit margin %11.29.0 124.0%  
BALANCE SHEET DATA
Current assets Rs m22,027117,062 18.8%   
Current liabilities Rs m13,32543,931 30.3%   
Net working cap to sales %27.242.7 63.7%  
Current ratio x1.72.7 62.0%  
Inventory Days Days4750 93.5%  
Debtors Days Days24683 296.7%  
Net fixed assets Rs m8,076117,166 6.9%   
Share capital Rs m1,6941,613 105.1%   
"Free" reserves Rs m13,297155,487 8.6%   
Net worth Rs m14,991157,100 9.5%   
Long term debt Rs m023,693 0.0%   
Total assets Rs m30,102234,228 12.9%  
Interest coverage x156.912.0 1,303.6%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x1.10.7 145.3%   
Return on assets %12.07.4 161.3%  
Return on equity %23.99.8 242.6%  
Return on capital %37.013.1 281.3%  
Exports to sales %032.2 0.0%   
Imports to sales %0.93.4 25.0%   
Exports (fob) Rs mNA55,175 0.0%   
Imports (cif) Rs m2765,903 4.7%   
Fx inflow Rs m27856,036 0.5%   
Fx outflow Rs m2765,903 4.7%   
Net fx Rs m250,133 0.0%   
CASH FLOW
From Operations Rs m5,77930,685 18.8%  
From Investments Rs m4,1861,040 402.3%  
From Financial Activity Rs m-6,961-29,488 23.6%  
Net Cashflow Rs m3,0042,340 128.4%  

Share Holding

Indian Promoters % 0.0 15.0 -  
Foreign collaborators % 75.0 21.7 345.3%  
Indian inst/Mut Fund % 12.5 41.1 30.5%  
FIIs % 1.6 24.8 6.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 63.3 39.5%  
Shareholders   120,476 408,401 29.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   MOREPEN LABS  KREBS BIOCHEMICALS  FERMENTA BIOTECH  PFIZER  ABBOTT INDIA  



Today's Market

5 Factors Why Stock Markets Surged, Adani Wilmar's IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a strong note yesterday. Benchmark indices came out of their long slumber.

Related Views on News

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2019-20 Annual Report Analysis (Annual Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

Here's an analysis of the annual report of CIPLA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

More Views on News

Most Popular

These Are the Best Stocks to Own(Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

A Trading Hack to Multiply Profits(Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks(Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

The Road to 100 Baggers Begins Here(Profit Hunter)

Jul 22, 2021

How to be an early investor in future 100 baggers.

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying(Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Aug 3, 2021 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE GSK PHARMA WITH

MARKET STATS